EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Methylation Analysis of Tumour Suppressor Genes in Ovarian Cancer Using MS-MLPA

M Chmelařová, E Křepinská, J Spaček, J Laco, J Nekvindová, V Palička

Folia Biologica · 2012 · 58 (6) · 246-250

DOI: 10.14712/fb2012058060246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Biologica, online erschienen am 13.08.2024. Verfasst von M Chmelařová und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry and Diagnostics, Faculty Hospital, Faculty of Medicine Hradec Králové, Charles University-Prague, Hradec Králové,…. Hauptthemen laut MEDLINE: Genes, Tumor Suppressor. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky, Univerzita Karlova v Praze, Grantová Agentura, Univerzita Karlova.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic changes are considered to be a frequent event during tumour development. Hypermethylation of promoter CpG islands represents an alternative mechanism for inactivation of tumour suppressor genes, DNA repair genes, cell cycle regulators and transcription factors. The aim of this study was to investigate promoter methylation of specific genes in ovarian cancer by comparison with normal ovarian tissue. To search for epigenetic events we used methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) to compare the methylation status of 69 tissue samples of ovarian cancer with 40 control samples. Using a 15% cut-off for methylation, we observed significantly higher methylation in genes MGMT , PAX5 , CDH13 , WT1 , THBS1 , GATA5 in the ovarian cancer group, while in the ESR1 gene we observed significantly higher methylation in the control group compared with the ovarian cancer group. These findings could potentially be used in screening of ovarian cancer and may have implications for future chemotherapy based on epigenetic changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genes, Tumor SuppressorAdultCase-Control StudiesDNA MethylationFemaleGenes, NeoplasmHumansMiddle AgedMultiplex Polymerase Chain ReactionOvarian NeoplasmsPromoter Regions, Genetic

Autor:innen und Institutionen

  • Department of Clinical Biochemistry and Diagnostics, Faculty Hospital, Faculty of Medicine Hradec Králové, Charles University-Prague, Hradec Králové, Czech Republic. ChmelarovaMarcela@seznam.cz

Förderung

  • Ministerstvo Zdravotnictví Ceské Republiky
  • Univerzita Karlova v Praze
  • Grantová Agentura, Univerzita Karlova

Zitieren

APA

Chmelařová, M., Křepinská, E., Spaček, J., Laco, J., Nekvindová, J., & Palička, V. (2012). Methylation Analysis of Tumour Suppressor Genes in Ovarian Cancer Using MS-MLPA. Folia Biologica, 58(6), 246-250. https://doi.org/10.14712/fb2012058060246

Vancouver

Chmelařová M, Křepinská E, Spaček J, Laco J, Nekvindová J, Palička V. Methylation Analysis of Tumour Suppressor Genes in Ovarian Cancer Using MS-MLPA. Folia Biologica. 2012;58(6):246-250. doi:10.14712/fb2012058060246

BibTeX
@article{Chmelaov2012,
  author = {Chmelařová, M and Křepinská, E and Spaček, J and Laco, J and Nekvindová, J and Palička, V},
  title = {Methylation Analysis of Tumour Suppressor Genes in Ovarian Cancer Using MS-MLPA},
  journal = {Folia Biologica},
  year = {2012},
  volume = {58},
  number = {6},
  pages = {246--250},
  doi = {10.14712/fb2012058060246}
}
Kostenlos starten →